GlassScriptPhysician profile
Gene Freylikhman
NPI 1184727265
$185.74
in general payments reported to CMS, 2019-2025
8 companies · $72.59 in 2025
The $72.59 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.82 · 2022: $22.28 · 2023: $46.05 · 2025: $72.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $118.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $37.55 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $29.91 | 2025 | |
| Minerva Surgical, INC | $27.83 | 2023 | |
| Sumitomo Pharma America, INC. | $27.23 | 2025 | Myfembree |
| Exeltis, USA INC. | $22.28 | 2022 | |
| Hologic Sales and Service, LLC | $15.45 | 2025 | Acessa Provu System, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Novocure INC. | $14.50 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gene Freylikhman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.